Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 88

Sort by

Sort Order Select

Journal Articles

Salvage whole brain radiotherapy after methotrexate failure in primary cns lymphoma

Shayla Murray, Gustav Cederquist, Kathryn Tringale, Zachary Moore, Alexandra Dreyfuss, Beatrice Fregonese, Lauren Schaff, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon Imber

Blood (2025) 146 (Supplement 1): 3679.

https://doi.org/10.1182/blood-2025-3679

Published: 2025

Journal Articles

Implementation of a patient-reported outcome assessment during radiotherapy for mycosis fungoides and other cutaneous lymphomas

Kaitlyn Lapen, Beatrice Fregonese, Brittany King, Anna Torres, Viviane Liao, Alison Moskowitz, Zachary Epstein-Peterson, Robert Stuver, Steven Horwitz, Nikhil Mankuzhy, Roshal Patel, Alok Deshane, Alexandra Dreyfuss, Gustav Cederquist, Zachary Moore, Shamir Geller, Joachim Yahalom, Brandon Imber

Blood (2025) 146 (Supplement 1): 522.

https://doi.org/10.1182/blood-2025-522

Published: 2025

Journal Articles

Pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter, Phase 2 trial

Blood (2025) 146 (Supplement 1): 1850.

https://doi.org/10.1182/blood-2025-1850

Published: 2025

Journal Articles

Reduced-dose whole brain radiotherapy is an effective consolidation strategy for parenchymal-only secondary cns lymphoma

Gustav Cederquist, Shayla Murray, Kathryn Tringale, Zachary Moore, Alexandra Dreyfuss, Beatrice Fregonese, Lauren Schaff, Lorenzo Falchi, Michael Scordo, Christian Grommes, Joachim Yahalom, Brandon Imber

Blood (2025) 146 (Supplement 1): 7181.

https://doi.org/10.1182/blood-2025-7181

Published: 2025

Journal Articles

A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study

Blood (2025) 146 (Supplement 1): 3617.

https://doi.org/10.1182/blood-2025-3617

Published: 2025

Journal Articles

Does increased PET avidity predict follicular lymphoma transformation? evidence from a large observational study

Blood (2025) 146 (Supplement 1): 3605.

https://doi.org/10.1182/blood-2025-3605

Published: 2025

Journal Articles

CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab

Raphael Steiner, Allison M. Bock, Alex F. Herrera, Omer Zulfa, Marc Hoffmann, Sami Ibrahimi, Natalie Galanina, Hun Ju Lee, Michael Green, Ruitao Lin, Chelsea C. Pinnix, Alison Moskowitz, Joachim Yahalom, Dai Chihara

Blood (2024) 144 (Supplement 1): 4434.2.

https://doi.org/10.1182/blood-2024-202516

Published: 2024

Journal Articles

A Proof-of-Principle of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: A Phase 1a Pilot Cohort

Brandon S. Imber, Anna Brosoff, Emma Roszak, Devin McAvoy, Kinga K. Hosszu, Alexander P. Boardman, Parastoo B Dahi, Gunjan L. Shah, Michael Scordo, Jae H. Park, Miguel-Angel Perales, Gilles Salles, Maria Lia Palomba, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 3128.

https://doi.org/10.1182/blood-2024-210156

Published: 2024

Journal Articles

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2024-206398

Published: 2024

Journal Articles

Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin

Blood (2024) 144 (Supplement 1): 569.

https://doi.org/10.1182/blood-2024-202537

Published: 2024

Journal Articles

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Roshal R. Patel, Alexander Tward, Beatrice Fregonese, Harper Hubbeling, Kaitlyn Lapen, Nikhil P. Mankuzhy, Sandeep S. Raj, Miguel-Angel Perales, Roni Shouval, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 7164.

https://doi.org/10.1182/blood-2024-210814

Published: 2024

Journal Articles

Radiation Therapy in a New Era of Multiple Myeloma Management: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response

Alexandra Dreyfuss, Beatrice Fregonese, Saad Z. Usmani, Sham Mailankody, Brandon S. Imber, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2024-202628

Published: 2024

Journal Articles

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Blood (2024) 144 (Supplement 1): 4434.

https://doi.org/10.1182/blood-2024-210689

Published: 2024

Journal Articles

Improved Outcomes for Primary Refractory Classical Hodgkin Lymphoma: A Retrospective Analysis

Blood (2024) 144 (Supplement 1): 4429.

https://doi.org/10.1182/blood-2024-203857

Published: 2024

Journal Articles

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

Nikhil P. Mankuzhy, Brandon S. Imber, Paige Pammer, Beatrice Fregonese, Adriana Cajo, Gustav Cederquist, Alexandra Dreyfuss, Kaitlyn Lapen, Roshal R. Patel, Zachary R. Moore, Carla Hajj, Gilles Salles, Joachim Yahalom

Blood (2024) 144 (Supplement 1): 3040.

https://doi.org/10.1182/blood-2024-208916

Published: 2024

Journal Articles

Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

Manik Uppal, Ashwath Gurumurthi, Paul A. Hamlin, Lorenzo Falchi, Steven Horwitz, Anita Kumar, Ariela Noy, Jennifer Kimberly Lue, Pallawi Torka, Maria E. Arcila, Ahmet Dogan, Brandon S. Imber, Joachim Yahalom, Olivier Elemento, Andrew D. Zelenetz, Gilles Salles, Erel Joffe

Blood (2024) 144 (Supplement 1): 4346.

https://doi.org/10.1182/blood-2024-198931

Published: 2024

Journal Articles

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

Alex Tward, Roshal R. Patel, Irem Isgor, Pallavi Galera, Katherine Lopez, Beatrice Fregonese, Zachary Moore, Suzanne Wolden, Joachim Yahalom, Brandon S. Imber

Blood (2024) 144 (Supplement 1): 3097.

https://doi.org/10.1182/blood-2024-210577

Published: 2024

Journal Articles

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

Beatrice Fregonese, Carla Hajj, Silvano Gonzalez, Jisun Lee, Lily Boe, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6281.

https://doi.org/10.1182/blood-2023-190688

Published: 2023

Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom

Blood (2023) 142 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2023-185338

Published: 2023

Journal Articles

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Gustav Cederquist, Kathryn Tringale, Carla Hajj, Harper Hubbeling, Jennifer Ma, Alexandra Dreyfuss, Beatrice Fregonese, Gilles Salles, Christian Grommes, Michael Scordo, Lorenzo Falchi, Joachim Yahalom, Brandon S. Imber

Blood (2023) 142 (Supplement 1): 1759.

https://doi.org/10.1182/blood-2023-190236

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Salvage whole brain radiotherapy after methotrexate failure in primary cns lymphoma

Implementation of a patient-reported outcome assessment during radiotherapy for mycosis fungoides and other cutaneous lymphomas

Pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter, Phase 2 trial

Reduced-dose whole brain radiotherapy is an effective consolidation strategy for parenchymal-only secondary cns lymphoma

A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study

Does increased PET avidity predict follicular lymphoma transformation? evidence from a large observational study

CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab

A Proof-of-Principle of Split-Course Bridging Radiotherapy (SC-BRT) Prior to CAR T-Cell Therapies for Relapsed or Refractory B-Cell Lymphomas: A Phase 1a Pilot Cohort

Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin

Bridging Radiotherapy May Decrease Inflammation Prior to CAR-T Cell Therapy

Radiation Therapy in a New Era of Multiple Myeloma Management: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study

Improved Outcomes for Primary Refractory Classical Hodgkin Lymphoma: A Retrospective Analysis

Very Low Dose Radiotherapy (VLDRT) with 4 Gy for Potentially-Curable Indolent Non-Hodgkin Lymphomas

Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

Radiation Therapy for Burkitt Lymphoma: Multi-Decade Insights from a Single Center

Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

Radiotherapy As an Effective Bridge for Relapsed/Refractory Secondary CNS Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only